drugset / Trial / NCT01569191

Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis

NCT01569191

Phase 4 Completed 18 enrolled Aston University University of Worcester · collab
RandomizedCrossoverDouble-blindTreatment

Summary

Seasonal allergic conjunctivitis (SAC) is an irritating eye condition that affects many people, caused by hypersensitivity to normally harmless substances such as pollen, and often accompanies seasonal hay fever. Treatments that can be used before initiating medical therapy include artificial tear supplements (ATS) and cold compresses (CC). However, there is no evidence in the scientific literature that demonstrates their efficacy compared to no treatment or their combined effect with anti-allergic medication. Therefore the investigators aim to examine the efficacy of ATS and CC alone, in comparison to anti-allergic medication, and CC in combination with anti-allergic medication. In addition, the investigators also aim to determine the time course of ocular allergic reactions. At the end of the study the investigators will be able to see whether or not ATS and CC are effective in treating SAC.

Timeline

Start
2012-03
Primary completion
2012-11
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinastine Small molecule 500 ug/ml